These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 2697408

  • 1. Autologous BMT for AML without purging.
    Burnett AK.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():76-8. PubMed ID: 2697408
    [No Abstract] [Full Text] [Related]

  • 2. Autologous bone marrow transplantation in first remission AML--its relative value.
    de Gast GC, Zwaan FE, Hagenbeek T, Verdonck LF, Löwenberg B.
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():52-4. PubMed ID: 2202468
    [No Abstract] [Full Text] [Related]

  • 3. Results of autologous bone marrow transplantation for acute leukaemia.
    Gulati SC, Whitmarsh K, Reich L, Berman E, Yahalom J, Yopp J, Clarkson B, Gee T.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():61-4. PubMed ID: 2697438
    [No Abstract] [Full Text] [Related]

  • 4. Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocol.
    Zittoun R, Mandelli F, De Witte T, Willemze R, Tura S.
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():56-8. PubMed ID: 2202470
    [No Abstract] [Full Text] [Related]

  • 5. [Autotransplantation in acute nonlymphoid leukemia].
    Meloni G, Mandelli F.
    Haematologica; 1991 Jun; 76 Suppl 3():321-6. PubMed ID: 1752528
    [No Abstract] [Full Text] [Related]

  • 6. Acute myeloid leukemia and the position of autologous stem cell transplantation.
    Breems DA, Löwenberg B.
    Semin Hematol; 2007 Oct; 44(4):259-66. PubMed ID: 17961725
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients.
    Carella AM, Piatti G, Frassoni F, Maraone MP, Van Lint MT, Bacigalupo A.
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():55. PubMed ID: 2202469
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of intensive consolidation therapy and autologous bone marrow transplantation in acute myeloid leukaemia. The Leiden experience.
    Willemze R, Fibbe WE, Richel DJ, Kluin-Nelemans JC, Zwaan FE.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():73. PubMed ID: 2697407
    [No Abstract] [Full Text] [Related]

  • 9. Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia.
    Gulati SC, Shank B, Sarris A, Berman E, Gee T, Cunningham I, Flomenberg N, O'Reilly RJ, Clarkson B.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():116-8. PubMed ID: 2653485
    [No Abstract] [Full Text] [Related]

  • 10. Autologous bone marrow transplantation in patients with AML in second complete remission (CR).
    Meloni G, De Fabritiis P, Amadori S, Petti MC, Pulsoni A, Sandrelli A, Mandelli F.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():207-8. PubMed ID: 2653505
    [No Abstract] [Full Text] [Related]

  • 11. High dose therapy and autologous bone marrow transplant (ABMT) in acute leukemia: is purging necessary?
    Dicke KA, Spinolo JA.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():184-6. PubMed ID: 2653500
    [Abstract] [Full Text] [Related]

  • 12. Double intensification including autologous bone marrow transplantation (ABMT) in AML: long term follow-up and detection of residual disease.
    Dicke KA, Dicke-Evinger MJ, Spinolo JA, Estey EH, Kantarjian HM, Spitzer GS.
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():27-34. PubMed ID: 2390639
    [No Abstract] [Full Text] [Related]

  • 13. Allogeneic versus autologous bone marrow transplantation versus intensive post-remission chemotherapy in acute leukaemias.
    Bernasconi C, Lazzarino M, Canevari A, Morra E, Castelli G, Brusamolino E, Alessandrino EP, Pagnucco G, Orlandi E, Castagnola C.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():65-8. PubMed ID: 2697439
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA.
    Suciu S, Solbu G, Zittoun R, Hayat M, Willemze R, de Witte T, Mandelli F.
    Bone Marrow Transplant; 1991 Dec; 7 Suppl 2():34. PubMed ID: 1878707
    [No Abstract] [Full Text] [Related]

  • 16. Post remission therapy in acute myeloid leukaemia (AML): the Medical Research Council experience in the UK.
    Rees JK, Gray RG.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():70-1. PubMed ID: 2697405
    [No Abstract] [Full Text] [Related]

  • 17. Double autologous bone marrow transplantation in acute myeloid leukaemia.
    Gribben JG, Goldstone AH, Linch DC, MacMillan AK, Richards JD.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():209-11. PubMed ID: 2653506
    [No Abstract] [Full Text] [Related]

  • 18. Clinical studies of allogeneic marrow transplantation in patients with acute non-lymphoblastic leukaemia. Seattle Marrow Transplant Team.
    Buckner CD, Clift RA.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():82. PubMed ID: 2697410
    [No Abstract] [Full Text] [Related]

  • 19. Autologous BMT for ALL.
    Burnett AK.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():79-80. PubMed ID: 2697409
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.